Arrhythmias in Hemorrhagic Myocardial Infarction During the Acute Post-PCI Phase (MIRON-RHYTHM)

March 7, 2026 updated by: Rohan Dharmakumar

Prevalence of Arrhythmias in Hemorrhagic Myocardial Infarction During the Acute Post-PCI Phase

Prevalence of Arrhythmias in Hemorrhagic Myocardial Infarction During the Acute Post-PCI Phase

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

250

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • India
      • Rajkot, India
        • Synergy Cardiovascular Research Center
  • United States
    • Indiana
      • Indianapolis, Indiana, United States, 46202
        • IU School of Medicine/ IUHealth, Krannert Cardiovascular Research Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

N/A

Sampling Method

Non-Probability Sample

Study Population

Acute MI with Primary PCI

Description

  1. Age 18-85 years
  2. Index STEMI
  3. Coronary angiogram with Primary coronary intervention
  4. No contraindications for Cardiac MRI

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Prevalence of Ventricular Arrhytmia
Time Frame: 24 hours
Prevalence of Premature Ventricular Contractions (PVCs), Non-Sustained Ventricular Tachycardia (NSVT), and Ventricular Tachycardia/Ventricular Fibrillation (VT/VF) detected by post-PCI Holter monitoring.
24 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Rohan Dharmakumar

Investigators

  • Principal Investigator: Keyur P Vora, MD MS FACC, Indiana University School of Medicine
  • Study Director: Rohan Dharmakumar, PhD, Indiana University School of Medicine

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2022

Primary Completion (Actual)

December 10, 2024

Study Completion (Actual)

March 30, 2025

Study Registration Dates

First Submitted

September 23, 2024

First Submitted That Met QC Criteria

September 23, 2024

First Posted (Actual)

September 25, 2024

Study Record Updates

Last Update Posted (Actual)

March 10, 2026

Last Update Submitted That Met QC Criteria

March 7, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 19978f

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acute Myocardial Infarction

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Moldova

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe